Skip to main content
OpenTrials

Clinical trial condition

Mastocytosis, Systemic

Explore clinical trials studying Mastocytosis, Systemic. Study availability and eligibility vary by location and protocol.

37 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Mastocytosis, Systemic trial results

Recruiting

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

NCT04910685

Conditions
Immune System Diseases, Indolent Systemic Mastocytosis, Mast Cell Activation Disorders, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus Aurora, Colorado, United States
View all 71 locations
View Trial Details
Recruiting

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

NCT04996875

Conditions
Advanced Systemic Mastocytosis (AdvSM), Aggressive Systemic Mastocytosis (ASM), Bone Marrow Diseases, +35 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 42 locations
View Trial Details
Recruiting

A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany

NCT07255638

Conditions
Immune System Diseases, Indolent Systemic Mastocytosis, Mast Cell Activation Disorders, +6 more
Locations
  • Charité Universitätmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie Berlin, Germany
  • Katholisches Klinikum Bochum Bochum, Germany
  • MVZ Klinikum Deggendorf Deggendorf, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden Klinik und Poliklinik für Dermatologie Dresden, Germany
View Trial Details
Recruiting

Avapritinib Rollover Study

NCT06748001

Conditions
Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +5 more
Locations
  • Universitair Ziekenhuis Antwerpen (UZA) Edegem, Belgium
  • The Hospital for Sick Children Toronto, Ontario, Canada
  • A.O.U. San Giovanni di Dio e Ruggi d'Aragona di Salerno Salerno, Italy
  • Universitair Medisch Centrum Groningen Groningen, Netherlands
View Trial Details
Completed

(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis

NCT03580655

Conditions
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Hematologic Diseases, +15 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 32 locations
View Trial Details
Completed

Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis

NCT03401060

Conditions
Bone Diseases, Bone Diseases, Metabolic, Immune System Diseases, +12 more
Locations
  • Jean Minjoz Hospital, Dermatology department Besançon, France
  • Caen Hospital, Clinical haematology department Caen, France
  • Estaing Hospital, Cellular therapy and clinical haematology department Clermont-Ferrand, France
  • Lille CHRU Hospital, Internal medicine and clinical immunology department Lille, France
View Trial Details

Related conditions